These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 849644)

  • 1. Cell-mediated immunity in amyloidosis secondary to lepromatous leprosy.
    Anders EM; McAdam KP; Anders RF
    Clin Exp Immunol; 1977 Jan; 27(1):111-7. PubMed ID: 849644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
    Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
    J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
    Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.
    Sasiain MC; Ruibal Ares B; Baliña LM; Valdez R; Bachmann AE
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell regulation in Erythema Nodosum Leprosum.
    Negera E; Walker SL; Bobosha K; Howe R; Aseffa A; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006001. PubMed ID: 28991896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leprosy XII. Quantitative analysis of thymus-derived lymphocyte response to phytohemagglutinin in leprosy.
    Lim SD; Jacobson RR; Park BH; Good RA
    Int J Lepr Other Mycobact Dis; 1975; 43(2):95-100. PubMed ID: 1081499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH; Sieling PA
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
    Job CK; Jacobson RR; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of amyloidosis with erythema nodosum leprosum reactions and recurrent neutrophil leucocytosis in leprosy.
    McAdam KP; Anders RF; Smith SR; Russell DA; Price MA
    Lancet; 1975 Sep; 2(7935):572-3. PubMed ID: 51405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological immunological studies on leprosy in Okinawa. 6. Lepromin, lymphocyte transformation, FLA-ABS and leproagglutination tests in the in-and out-patients with leprosy and the relationships among these tests and personal or family history or clinical findings of the patients].
    Minagawa F; Yoshino Y; Abe M; Saito N; Ohsawa Y; Ozawa T; Saikawa K
    Nihon Rai Gakkai Zasshi; 1989; 58(2):92-111. PubMed ID: 2697714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
    Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunologic status of healthy members of families with a history of leprosy.
    Price MA; Anders EM; Anders RF; Russel DA; Dennis ES
    Int J Lepr Other Mycobact Dis; 1975; 43(4):307-13. PubMed ID: 1241686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary amyloidosis and the serum amyloid precursor in leprosy: geographical variation and association with leukocytosis.
    McAdam KP; Anders RF; Aiken G; Takitaki FF
    Int J Lepr Other Mycobact Dis; 1977; 45(2):150-7. PubMed ID: 561759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of C4B deficiency (C4B*Q0) with erythema nodosum in leprosy.
    de Messias IJ; Santamaria J; Brenden M; Reis A; Mauff G
    Clin Exp Immunol; 1993 May; 92(2):284-7. PubMed ID: 8485914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum.
    Walker SL; Balagon M; Darlong J; Doni SN; Hagge DA; Halwai V; John A; Lambert SM; Maghanoy A; Nery JA; Neupane KD; Nicholls PG; Pai VV; Parajuli P; Sales AM; Sarno E; Shah M; Tsegaye D; Lockwood DN;
    PLoS Negl Trop Dis; 2015; 9(9):e0004065. PubMed ID: 26351858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defect in the generation of cytotoxic T cells in lepromatous leprosy.
    Stach JL; Strobel M; Fumoux F; Bach JF
    Clin Exp Immunol; 1982 Jun; 48(3):633-40. PubMed ID: 6214342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tr, T mu and B lymphocytes in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Indian J Lepr; 1986; 58(4):601-8. PubMed ID: 2952738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on T cell subsets and functions in leprosy.
    Bach MA; Chatenoud L; Wallach D; Phan Dinh Tuy F; Cottenot F
    Clin Exp Immunol; 1981 Jun; 44(3):491-500. PubMed ID: 6459897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.